Novavax Inc. promoted John Trizzino to senior vice president, chief business officer and CFO.
Trizzino, who originally joined Novavax in 2009, has been serving as senior vice president of commercial operations since 2014.
Novavax President and CEO Stanley Erck had been performing CFO duties on an interim basis after Barclay Phillips stepped down Nov. 10, 2017.
Novavax is a Gaithersburg, Md.-based clinical-stage biotechnology company that focuses on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants.
